C2 Therapeutics | Coldplay CryoBalloon Focal Ablation System
The chief advantage of this cryotherapy technology for Barrett's esophagus — and it's a
big advantage — is that it expands gastro docs' opportunities for ablation treatment with-
out demanding a major capital investment. The fact that it's a handheld device with no
large equipment to wheel in means that the nurses who set up the cases will appreciate
it, too.
The system ablates lesions with a single-use balloon catheter that's passed through
an endoscope's working channel, then inflated and cooled by a cartridge of nitrous
oxide plugged into a single-use, self-contained, battery-powered control handle. The
balloon conforms to the shape of the esophagus and a precise spray of the inert coolant
treats the lesions. No $100,000 radiofrequency ablation generator or huge tank of liq-
uid nitrogen necessary.
A rep from C2 Therapeutics says the product, which is currently in a "contained com-
mercial launch," is expect-
ed to be priced to a similar
cost-per-case as other abla-
tion methods.
7 2
O U T P A T I E N T S U R G E R Y M A G A Z I N E O N L I N E | J U LY 2 0 1 5
WWW.CYGNUSMEDICAL.COM | 800.990.7489
z FEEL THE CHILL
A supercooled bal-
loon catheter
ablates Barrett's
esophagus without
heavy equipment.
